53例成人Still病临床特征分析及文献复习

李咏, 马科. 53例成人Still病临床特征分析及文献复习[J]. 临床急诊杂志, 2017, 18(6): 437-440. doi: 10.13201/j.issn.1009-5918.2017.06.009
引用本文: 李咏, 马科. 53例成人Still病临床特征分析及文献复习[J]. 临床急诊杂志, 2017, 18(6): 437-440. doi: 10.13201/j.issn.1009-5918.2017.06.009
LI Yong, MA Ke. Analysis of clinical characteristics of fifty-three patients with adult onset still disease and literature review[J]. J Clin Emerg, 2017, 18(6): 437-440. doi: 10.13201/j.issn.1009-5918.2017.06.009
Citation: LI Yong, MA Ke. Analysis of clinical characteristics of fifty-three patients with adult onset still disease and literature review[J]. J Clin Emerg, 2017, 18(6): 437-440. doi: 10.13201/j.issn.1009-5918.2017.06.009

53例成人Still病临床特征分析及文献复习

详细信息
    通讯作者: 马科, E-mail:markusleo@hotmail.com
  • 中图分类号: R593.2

Analysis of clinical characteristics of fifty-three patients with adult onset still disease and literature review

More Information
  • 目的: 通过对53例成人Still病例临床资料进行回顾性分析,以提高对该病的诊疗水平。方法: 回顾性分析我院53例成人Still病患者的临床资料、辅助检查和疾病预后转归情况。结果: 在回顾性分析中,女性患者较男性患者例数更多(52.8% vs.47.2%),发生严重并发症如多器官功能损害、噬血综合征等的患者预后较差。基线降钙素原、白介素-6、C反应蛋白、血沉、白细胞计数、中性粒细胞百分比在不同预后患者之间无明显差异。预后好患者治疗后铁蛋白水平明显低于预后差患者[(4 898±8 938) μg/L vs.(31 810±17 710) μg/L,P<0.001],预后好患者在治疗后铁蛋白水平较治疗前明显下降[(4 898±8 938) μg/L vs.(14 270±19 070) μg/L,P<0.001],预后差患者治疗后铁蛋白水平较治疗前仍持续上升[(31 810±17 710) μg/L vs.(15 240±22 150) μg/L,P<0.001]。结论: 成人Still病是以发热、皮疹、关节疼痛为主要特征的一类疾病,铁蛋白对患者的诊断和治疗具有较好的预测效果,大部分患者通过治疗预后较好,少部分出现严重并发症的患者预后差。
  • 加载中
  • [1]

    Bagnari V, Colina M, Ciancio G, et al.Adult-onset Still's disease[J].Rheumatol Int, 2010, 30 (7):855-862.

    [2]

    翟永志, 杨光, 张志强, 等.不明原因发热229例病因诊断[J].中国全科医学, 2011, 14 (24):2773-2774.

    [3]

    Yamaguchi M, Ohta A, Tsunecmatsu T, et al.Preliminary criteria for classification of adult Still's disease[J].J Rhecumatol, 1992, 19 (3):424-430.

    [4]

    中华医学会风湿病学分会.成人斯蒂尔病诊断及治疗指南[J].中华风湿病学杂志, 2010, 14 (7):487-489.

    [5]

    Kádár J, Petrovicz E.Adult-onset Still's disease[J].Best Pract Res Clin Rheumatol, 2004, 18 (5):663-676.

    [6]

    Aikawa N E, Ribeiro A C, Saad C G, et al.Is anti-TNF switching in refractory Still's disease safe and effective?[J].Clin Rheumatol, 2011, 30 (8):1129-1134.

    [7]

    Chen D Y, Lan J L, Lin F J, et al.Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease[J].J Rheumatol, 2004, 31 (11):2189-2198.

    [8]

    Maria A T, Le Quellec A, Jorgensen C, et al.Adult onset Still's disease (AOSD) in the era of biologic therapies:dichotomous view for cytokine and clinical expressions[J].Autoimmun Rev, 2014, 13 (11):1149-1159.

    [9]

    杨岫岩, 梁柳琴, 许韩师, 等.尼美舒利与甲氨蝶吟联合治疗成人斯蒂尔病的随机临床试验[J].中国药物与临床, 2002, 2 (4):213-216.

    [10]

    Fautrel B, Le Moël G, Saint-Marcoux B, et al.Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease[J].J Rheumatol, 28 (2):322-329.

    [11]

    Bae C B, Jung J Y, Kim H A, et al.Reactive hemophagocytic syndrome in adult-onset Still disease:clinical features, predictive factors, and prognosis in 21 patients[J].Medicine (Baltimore), 2015, 94 (4):e451.

    [12]

    Albet J B, Le T H, Marinho A, et al.Reactive haemophagocytic syndrome in adult-onset Still's disease:a report of six patients and a review of the literature[J].Ann Rheum Dis, 2006, 65 (12):1596-1601.

    [13]

    Fischer-Betz R, Specker C, Schneider M.Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1receptor antagonist[J].Clin Exp Rheumatol, 2011, 29 (6):1021-1023.

  • 加载中
计量
  • 文章访问数:  237
  • PDF下载数:  444
  • 施引文献:  0
出版历程
收稿日期:  2017-05-09

目录